Pharmacyclics Divisional Patent Application Upheld by Calcutta High Court
Calcutta High Court upholds Pharmacyclics divisional patent application for ibrutinib-anti-CD20 therapy, interpreting Section 16 of the Patents Act, 1970.
5 articles
Calcutta High Court upholds Pharmacyclics divisional patent application for ibrutinib-anti-CD20 therapy, interpreting Section 16 of the Patents Act, 1970.
Changes in Indian patent rules now make it feasible to obtain patent grants within a year of filing. BananaIP Counsels is hosting a seminar on 23rd November 2019…
The Indian Patent Office recently granted a patent for biodegradable leafy straws in less than seven months, demonstrating the benefits of expedited examination and compliance with revised rules.…
This post examines a patent pending invention aimed at improving the safety and security of two-wheeled vehicle stands. The analysis details how the invention provides enhanced control and…
This post examines two significant sex patents filed in India, focusing on their claims and the Indian Patent Office’s examination process. It discusses issues of novelty, inventive step,…